CELL — Cellularline SpA Cashflow Statement
0.000.00%
Last trade - 00:00- €59.11m
- €82.51m
- €158.65m
- 69
- 84
- 68
- 88
Annual cashflow statement for Cellularline SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 18.2 | 13.9 | -3.85 | -75.2 | 3.6 |
| Depreciation | |||||
| Non-Cash Items | 4.21 | -16 | -0.525 | 1.34 | 1.83 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.9 | -1.45 | 4.46 | -9.35 | -5.79 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 20.3 | 11.3 | 19.1 | 4.89 | 13 |
| Capital Expenditures | -8.31 | -10.2 | -5 | -4.61 | -4.89 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.57 | -13.8 | -2.37 | -0.786 | -2.55 |
| Acquisition of Business | |||||
| Cash from Investing Activities | -9.88 | -24 | -7.36 | -5.39 | -7.45 |
| Financing Cash Flow Items | 1.92 | 6.86 | -3.3 | -1.32 | -0.837 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -20.4 | -10.8 | -12.9 | 1.48 | -2.56 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.99 | -23.5 | -0.491 | 1.78 | 4.13 |